102 related articles for article (PubMed ID: 25007180)
1. Immunohistochemical visualization of pro-inflammatory cytokines and enzymes in ovarian tumors.
Plewka D; Kowalczyk AE; Jakubiec-Bartnik B; Morek M; Bogunia E; Kmiec A; Wierzbicki PM; Plewka A
Folia Histochem Cytobiol; 2014; 52(2):124-37. PubMed ID: 25007180
[TBL] [Abstract][Full Text] [Related]
2. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation.
Yun KJ; Koh DJ; Kim SH; Park SJ; Ryu JH; Kim DG; Lee JY; Lee KT
J Agric Food Chem; 2008 Nov; 56(21):10265-72. PubMed ID: 18841975
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation activity unrelated to COX-2 expression in ovarian tumors.
Yoshida A; Sarian LO; Andrade LA; Pignataro F; Pinto GA; Derchain SF
Int J Gynecol Cancer; 2007; 17(3):607-14. PubMed ID: 17504375
[TBL] [Abstract][Full Text] [Related]
7. Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells.
Shin JS; Park YM; Choi JH; Park HJ; Shin MC; Lee YS; Lee KT
Int Immunopharmacol; 2010 Aug; 10(8):943-50. PubMed ID: 20546946
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression in borderline ovarian tumors.
Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G
Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages.
Plewka A; Madej P; Plewka D; Kowalczyk A; Miskiewicz A; Wittek P; Leks T; Bilski R
Folia Histochem Cytobiol; 2013; 51(1):73-83. PubMed ID: 23690221
[TBL] [Abstract][Full Text] [Related]
12. Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer.
Martins Filho A; Jammal MP; Côbo Ede C; Silveira TP; Adad SJ; Murta EF; Nomelini RS
Immunol Lett; 2014; 158(1-2):195-9. PubMed ID: 24447864
[TBL] [Abstract][Full Text] [Related]
13. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Umesalma S; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):650-5. PubMed ID: 20406206
[TBL] [Abstract][Full Text] [Related]
15. Majoon ushba, a polyherbal compound ameliorates rheumatoid arthritis via regulating inflammatory and bone remodeling markers in rats.
Ganesan R; Doss HM; Rasool M
Cytokine; 2016 Jan; 77():115-26. PubMed ID: 26556105
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 expression in serous tumors of the ovary.
Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
[TBL] [Abstract][Full Text] [Related]
17. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
[TBL] [Abstract][Full Text] [Related]
18. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
Ozel E; Peştereli HE; Simşek T; Erdoğan G; Karaveli FS
Int J Gynecol Cancer; 2006; 16(2):549-55. PubMed ID: 16681724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]